Want to join the conversation?
$CELG's second pivotal trial CD-003 will initiate in a staggered parallel fashion early in 2016 and completion timing is similar to that of CD-002. The endoscopy study CD-001 is actively enrolling and the company expects to complete enrollment by year-end 2015. This study has an off-drug observation period up to 52 weeks.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.
$FHN shares have dropped after its earnings missed analysts’ expectations. I’m worried whether the stock will slide further.